The analysis of T cell infiltrates in the tumor sites revealed that all combinations of tumor-derived vaccines induced an increased CD8 T cell infiltration (Figure 5D) and enhanced the CD8/Treg ratio (Figure 5C). The gene discussed is CD8A; the disease is neoplasm.